Stress hyperglycemia in acute ST-segment elevation myocardial infarction is a marker of left ventricular remodeling

Danijela Djordjevic-Radojkovic1, Goran Koracevic, Dragana Stanojevic

  • 1Clinic for cardiovascular diseases, Clinical Center, Nis, Serbia.

Acute Cardiac Care
|June 7, 2013
PubMed

Insights

Stress hyperglycemia (SH) in ST-elevation myocardial infarction (STEMI) significantly increases in-hospital mortality risk. SH may also indicate left ventricular (LV) remodeling one year post-STEMI.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Stress hyperglycemia (SH) in ST-elevation myocardial infarction (STEMI) is linked to increased in-hospital mortality.
  • The role of SH as a predictor of long-term post-hospital risk and left ventricular (LV) remodeling remains debated.

Purpose of the Study:

  • To evaluate the in-hospital and one-year risks associated with SH in STEMI patients.
  • To determine if SH serves as a marker for LV remodeling post-STEMI.

Main Methods:

  • A cohort of 275 STEMI patients undergoing reperfusion therapy was analyzed.
  • Patients were stratified into three groups: pre-existing diabetes mellitus (DM), SH without DM, and neither DM nor SH.
  • SH was defined as admission blood glucose ≥ 8 mmol/l.

Main Results:

  • In-hospital mortality was highest in the SH without DM group (9.3%) compared to DM (5%) and control (1.6%) groups (P < 0.05).
  • For patients without known DM, SH was associated with a 6.378-fold increase in in-hospital mortality.
  • End-diastolic volume (EDV) significantly increased in the SH without DM group over one year (126 ± 37 to 145 ± 30 ml, P < 0.05), suggesting LV remodeling.

Conclusions:

  • SH in STEMI patients is a significant predictor of high in-hospital mortality.
  • SH may serve as a marker for adverse LV remodeling, evidenced by increased EDV over one year.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...